Terms: = Endocrine gland cancer AND RNF43, DKFZp781H02126, 54894, Q68DV7, URCC, RNF124, MGC125630, FLJ20315, DKFZp781H0392 AND Treatment
8 results:
1. rnf43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in cancer Cells.
Hsu SH; Tsai YL; Wang YT; Shen CH; Hung YH; Chen LT; Hung WC
Adv Sci (Weinh); 2024 Mar; 11(12):e2304820. PubMed ID: 38225722
[TBL] [Abstract] [Full Text] [Related]
2. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract] [Full Text] [Related]
3. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic cancer.
Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW
Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331
[TBL] [Abstract] [Full Text] [Related]
4. Loss of rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
Hosein AN; Dangol G; Okumura T; Roszik J; Rajapakshe K; Siemann M; Zaid M; Ghosh B; Monberg M; Guerrero PA; Singhi A; Haymaker CL; Clevers H; Abou-Elkacem L; Woermann SM; Maitra A
Gastroenterology; 2022 Apr; 162(4):1303-1318.e18. PubMed ID: 34973294
[TBL] [Abstract] [Full Text] [Related]
5. GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments.
Feng Y; Jiang Y; Hao F
J Transl Med; 2021 Aug; 19(1):373. PubMed ID: 34461940
[TBL] [Abstract] [Full Text] [Related]
6. Acquired resistance to immunotherapy in MMR-D pancreatic cancer.
Hu ZI; Hellmann MD; Wolchok JD; Vyas M; Shia J; Stadler ZK; Diaz LA; O'Reilly EM
J Immunother Cancer; 2018 Nov; 6(1):127. PubMed ID: 30458888
[TBL] [Abstract] [Full Text] [Related]
7. Integrated Molecular Characterization of the Lethal Pediatric cancer Pancreatoblastoma.
Isobe T; Seki M; Yoshida K; Sekiguchi M; Shiozawa Y; Shiraishi Y; Kimura S; Yoshida M; Inoue Y; Yokoyama A; Kakiuchi N; Suzuki H; Kataoka K; Sato Y; Kawai T; Chiba K; Tanaka H; Shimamura T; Kato M; Iguchi A; Hama A; Taguchi T; Akiyama M; Fujimura J; Inoue A; Ito T; Deguchi T; Kiyotani C; Iehara T; Hosoi H; Oka A; Sanada M; Tanaka Y; Hata K; Miyano S; Ogawa S; Takita J
Cancer Res; 2018 Feb; 78(4):865-876. PubMed ID: 29233928
[TBL] [Abstract] [Full Text] [Related]
8. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
[TBL] [Abstract] [Full Text] [Related]
